BioPharma Drive: Drug Pricing

JULY 2, 2025

Researchers had hoped the medicine would show an improvement for patients on an 11-point scale of pelvic pain compared with placebo after three months of twice-daily treatments. Organon’s head of research called the results disappointing in a statement Wednesday, but said endometriosis remains among the company’s targets in women’s health.

Clinical Trials

BioPharma Drive: Drug Pricing

MAY 15, 2025

drug production, but cautioned plans could change amid shifting Trump administration policies. The French drugmaker joined several peers in promising new investments in U.S.

Drug Research

BioPharma Drive: Drug Pricing

DECEMBER 12, 2023

Just before clearing Pfizer’s buyout of Seagen, the regulator threatened to block Sanofi’s licensing deal with Maze Therapeutics, a challenge the biotech called ‘‘unprecedented.”

Drug Research

BioPharma Drive: Drug Pricing

MAY 21, 2024

Since pivoting from oncology, the startup has raised close to $300 million and advanced an ulcerative colitis drug into mid-stage testing.

Drug Research

BioPharma Drive: Drug Pricing

AUGUST 22, 2023

Billing itself as both a scientific and investment partner, Foundery aims to provide research grants and drug development support to researchers developing new immunotherapies.

Research

BioPharma Drive: Drug Pricing

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Drug Research

BioPharma Drive: Drug Pricing

SEPTEMBER 25, 2024

The offering, which was upsized twice, will support development of a drug the company believes can boost the effects of popular weight loss medicines like Eli Lilly’s Zepbound.

Drug Research

BioPharma Drive: Drug Pricing

SEPTEMBER 7, 2023

The Series B round makes Mariana one of the best funded private companies in a growing group of biotechs working on new radiopharmaceutical therapies.

Drug Research

BioPharma Drive: Drug Pricing

APRIL 22, 2024

A new initiative backed by Takeda, Astellas and Sumitomo Mitsui Banking aims to combat a decade-long decline in drug R&D productivity in Japan.

Drug Research

BioPharma Drive: Drug Pricing

MARCH 1, 2024

The cash will be used to advance development of FOG-001, the company’s lead drug that’s now being tested in an early-stage trial for solid tumors.

Drug Research

BioPharma Drive: Drug Pricing

JUNE 18, 2024

Belharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere, Regenxbio mapped a regulatory path and Taysha shared updated results for its Rett treatment.

Drug Research

BioPharma Drive: Drug Pricing

DECEMBER 7, 2023

The funding is indicative of investor interest in an area of drug research that involves at least a dozen startups and multiple publicly traded companies.

Drug Research

BioPharma Drive: Drug Pricing

JANUARY 12, 2024

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

Drug Research

BioPharma Drive: Drug Pricing

DECEMBER 13, 2023

The company is now expecting to save $4 billion by the end of 2024, with a majority of the spending cuts coming from drug research and development.

Drug Research

Drugs.com

OCTOBER 24, 2023

23, 2023 -- New research suggests a link between middle school students being disciplined for marijuana use and legalization of recreational weed, particularly when schools are close to dispensaries that sell the drug. Researchers. MONDAY, Oct.

Drugs

BioPharma Drive: Drug Pricing

JULY 11, 2023

RA Capital led a Series B financing round that drew participation from more than a dozen blue-chip venture backers, including new investors Goldman Sachs and Vertex Ventures.

Drug Research

BioPharma Drive: Drug Pricing

JULY 5, 2023

The deal enables Sarepta to quickly cash in on the clearance of Elevidys, with $102 million in new funds to help bankroll its drug research.

Therapies

BioPharma Drive: Drug Pricing

MARCH 7, 2025

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy and Pfizer hired a scientist well versed in GLP-1 science.

Science

BioPharma Drive: Drug Pricing

AUGUST 15, 2023

More than a dozen startups have joined a few publicly traded biotechs and larger pharmaceutical firms in what’s become one of the most competitive areas in drug research.

Drug Research

BioPharma Drive: Drug Pricing

AUGUST 16, 2024

Some industry watchers described the level of price discounts announced by Medicare as a "relief," though they warned of bigger future implications for drug research.

Drugs

BioPharma Drive: Drug Pricing

JANUARY 9, 2025

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Drug Research

BioPharma Drive: Drug Pricing

OCTOBER 22, 2024

A medicine the pharma acquired in a $430 million buyout of Visterra in 2018 succeeded in a Phase 3 trial in IgA nephropathy, a crowded corner of drug research.

Disease

BioPharma Drive: Drug Pricing

MARCH 12, 2024

Allogene’s partnership with Arbor is designed to help the company stand out in what’s quickly become one of the industry’s hottest areas of drug research.

Therapies

BioPharma Drive: Drug Pricing

JUNE 14, 2023

The alliance is Astellas’ second recent partnership involving protein degraders, an emerging area of drug research the company has made a focus in recent years.

Drugs

BioPharma Drive: Drug Pricing

FEBRUARY 28, 2024

Well-known scientist and biotech entrepreneur Robert Langer is helping Lindus Health address longstanding challenges in contract drug research.

Drug Research

BioPharma Drive: Drug Pricing

NOVEMBER 22, 2024

Despite plans to shutter 1,200 stores, the company’s chief clinical trials officer said the pharmacy giant remains committed to aiding drug research.

Clinical Trials

BioPharma Drive: Drug Pricing

JULY 26, 2023

The startup, which initially aims to make cancer medicines, claims to have a new twist on covalent drug research.

Drugs

BioPharma Drive: Drug Pricing

JULY 6, 2023

The contract services provider, which secured the deal through a reportedly competitive process, expects CorEvitas to expand its drug research business.

Drug Research

Chemical Biology and Drug Design

FEBRUARY 25, 2025

However, the effect of resveratrol on chronic rhinosinusitis (CRS) still lacks systematic research. Together, the present study systematically clarified the possible mechanisms of RES in the treatment of CRS and provided new ideas for the drug research of this disease.

Treatment

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7

Clinical Research

Chemical Biology and Drug Design

JULY 5, 2024

Abstract Intestinal absorption of compounds is significant in drug research and development. The QSPR model accurately predicted the intestinal absorption of molecules, and the computer simulation found the mechanism of molecular structure affecting intestinal absorption.

Drug Research

DrugBank

AUGUST 20, 2024

The world of drug discovery is in a state of transformation, with advancements in biotechnology opening doors to new possibilities for targeting previously "undruggable" disease mechanisms. The Power of Drug Repurposing Explore the immense potential of drug repurposing as a strategy for targeting undruggable targets.

Therapies

DrugBank

SEPTEMBER 12, 2024

At DrugBank we’re committed to improving your daily research and drug development operations. It’s designed to fit naturally into your existing processes, enhancing your ability to collaborate with standardized definitions and focus on your research tasks.

Production

Drug Target Review

SEPTEMBER 21, 2023

Introduction I clearly remember an incident as a researcher, which kept happening, from my undergraduate research up till now. Summary of research The undergraduate study concentrated on the potential adulticidal effects of oral analgesics (acetaminophen, aspirin, and ibuprofen) on Onchocerca volvulus. doi: 10.1002/14651858.CD011146.pub2.

Drugs

Drug Channels

MARCH 5, 2024

The potential effect of the IRA on manufacturers’ new drug research and development strategies is beyond the scope of this webinar. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Pharmacies and Pharmacy Benefit Managers. Read on for full details on pricing and registration.

Pharmacy

Crown Bioscience

MARCH 14, 2025

The Importance of Biomarkers in Drug Development Biomarkers have become essential tools in modern drug discovery and development, enabling researchers to predict drug efficacy, monitor disease progression, and tailor treatments to specific patient populations.

Drug Development

DrugBank

MAY 15, 2024

The Evolution of Drug Discovery: From Dark Rooms to Precision Targets In the past, drug discovery often felt like a lucky guess. Researchers would sift through natural extracts , hoping to stumble upon a compound that exhibited beneficial effects. In fact, it's one of the most exciting areas in drug research today.

Small Molecule